Research Progress of Granulocyte Colony Stimulating Factor in the Treatment of Liver Failure

Corresponding author: Zhaoxiaofang, 1105320747@qq.com

DOI: 10.12201/bmr.202505.00003

•  

  Abstract: Liver failure is a high-risk and high-mortality disease, and its pathogenesis is not yet fully understood. As an important cytokine, granulocyte-colony stimulating factor (G-CSF) has an important role in the clinical treatment of liver failure. The aim of this review is to summarize and analyze the research progress in recent years on the mechanism of G-CSFs role in liver failure, including its effects on hepatocyte regeneration, immunomodulation, survival improvement, and safety of clinical use.

  Key words: Granulocyte colony-stimulating factor; Liver failure; Hepatocyte regeneration; Regulation of immunity

  Submit time: 9 May 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• wangminggang, luojuan, mozhengyuan, chenxinxin, wangxiufeng. The Role of Immune Cells and Traditional Chinese Medicine in Acute-on-Chronic Liver Failure. 2025. doi: 10.12201/bmr.202504.00030

  Zhulei. Research Progress on Drug-induced Liver Injury with Immune Characteristics. 2025. doi: 10.12201/bmr.202504.00001

  wang zhong. Plasma C1q/ tumor necrosis factor-associated protein 6 and systemic inflammatory response index levels in patients with heart failure and their clinical significance. 2025. doi: 10.12201/bmr.202501.00060

  LI JIE. Research Advances in Heart Failure with Preserved Ejection Fraction Complicated by Chronic Kidney Disease. 2025. doi: 10.12201/bmr.202504.00077

  liumiao, yuanfangxiu, wangling, zengqiongjuan, zhuyuzhen, tujiaojiao, wangjun. . 2024. doi: 10.12201/bmr.202408.00006

  HONG Liang, PAN Anna, WU Yanghe, YE Xiaoting. Esculin improve lipid accumulation in hepatocytes by inhibiting the PERK/eIF2A/ATF4 signaling pathway. 2024. doi: 10.12201/bmr.202409.00013

  LUAN Zhi-Yong. Research progress of stem cell therapy for Hirschsprung disease. 2024. doi: 10.12201/bmr.202410.00021

  Research progress of red blood cell storage lesion. 2025. doi: 10.12201/bmr.202502.00021

  NIU Xiao Shan. Advances in pharmacological studies of NF-κB involved in the regulation of nonalcoholic fatty liver disease. 2024. doi: 10.12201/bmr.202410.00006

  王馨雨, ZHANG Shujuan. Research progress of GLP-2 in non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202502.00018

• ID	Submit time	Number	Download
  1	2025-02-25	bmr.202505.00003V1	Download

• Public  Anonymous  To author only Submit Comments